These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26657906)

  • 1. [BARRIER FUNCTION AND CUTANEOUS IMMUNOLOGY].
    Otsuka A; Kabashima K
    Arerugi; 2015 Sep; 64(9):1189-95. PubMed ID: 26657906
    [No Abstract]   [Full Text] [Related]  

  • 2. Our evolving understanding of the functional role of filaggrin in atopic dermatitis.
    Leung DY
    J Allergy Clin Immunol; 2009 Sep; 124(3):494-5. PubMed ID: 19733296
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetics of skin barrier impairment in atopic dermatitis].
    Audigier V; Shisha A; Jullien D
    Ann Dermatol Venereol; 2008 Jan; 135(1):34-7. PubMed ID: 18342071
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases.
    Kubo A; Nagao K; Amagai M
    J Clin Invest; 2012 Feb; 122(2):440-7. PubMed ID: 22293182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin barrier function in atopic dermatitis.
    Vickery BP
    Curr Opin Pediatr; 2007 Feb; 19(1):89-93. PubMed ID: 17224668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights in the pathogenesis of atopic dermatitis.
    Ong PY
    Pediatr Res; 2014 Jan; 75(1-2):171-5. PubMed ID: 24192701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling.
    Amano W; Nakajima S; Kunugi H; Numata Y; Kitoh A; Egawa G; Dainichi T; Honda T; Otsuka A; Kimoto Y; Yamamoto Y; Tanimoto A; Matsushita M; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2015 Sep; 136(3):667-677.e7. PubMed ID: 26115905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filaggrin mutations and atopy: consequences for future therapeutics.
    Heimall J; Spergel JM
    Expert Rev Clin Immunol; 2012 Feb; 8(2):189-97. PubMed ID: 22288457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin barrier function and allergic risk.
    Hudson TJ
    Nat Genet; 2006 Apr; 38(4):399-400. PubMed ID: 16570058
    [No Abstract]   [Full Text] [Related]  

  • 10. IL-33 impacts on the skin barrier by downregulating the expression of filaggrin.
    Seltmann J; Roesner LM; von Hesler FW; Wittmann M; Werfel T
    J Allergy Clin Immunol; 2015 Jun; 135(6):1659-61.e4. PubMed ID: 25863977
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.
    Yokouchi M; Kubo A; Kawasaki H; Yoshida K; Ishii K; Furuse M; Amagai M
    J Dermatol Sci; 2015 Jan; 77(1):28-36. PubMed ID: 25511077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrier dysfunction in the skin allergy.
    Egawa G; Kabashima K
    Allergol Int; 2018 Jan; 67(1):3-11. PubMed ID: 29153780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are epidermal defects the key initiating factors in the development of atopic dermatitis?
    Simpson E
    Br J Dermatol; 2010 Dec; 163(6):1147-8. PubMed ID: 21137113
    [No Abstract]   [Full Text] [Related]  

  • 14. Future trends in the treatment of atopic dermatitis.
    Igawa K
    Immunol Med; 2019 Mar; 42(1):10-15. PubMed ID: 31204894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.
    Elias PM; Wakefield JS
    Clin Rev Allergy Immunol; 2011 Dec; 41(3):282-95. PubMed ID: 21174234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of filaggrin loss-of-function mutations in atopic dermatitis.
    O'Regan GM; Irvine AD
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):406-10. PubMed ID: 18769192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the causes of atopic dermatitis in children: less foods, more mites.
    Fuiano N; Incorvaia C
    Allergol Int; 2012 Jun; 61(2):231-43. PubMed ID: 22361514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heritable filaggrin disorders: the paradigm of atopic dermatitis.
    McLean WH; Irvine AD
    J Invest Dermatol; 2012 Nov; 132(E1):E20-1. PubMed ID: 23154627
    [No Abstract]   [Full Text] [Related]  

  • 19. Filaggrin and the great epidermal barrier grief.
    McGrath JA
    Australas J Dermatol; 2008 May; 49(2):67-73; quiz 73-4. PubMed ID: 18412804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis.
    Thyssen JP; Kezic S
    J Allergy Clin Immunol; 2014 Oct; 134(4):792-9. PubMed ID: 25065719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.